Research Article
GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism
Table 4
Change of immunosuppressive regimens.
| | SS/NEX group () | SS/EX group () | LS/NEX group () | LS/EX group () |
| | FK506-to-CSA conversion | | | | | | Case number (%) | 2 (5.0) | 6 (15.8) | 1 (2.1) | 18 (37.5) | | Starting days after LT | 143 (15-270) | 32 (8-122) | 14 | 22 (10-75) | | Additional use of MMF | | | | | | Case number | 17 (42.5) | 30 (78.9) | 16 (33.3) | 29 (60.4) | | Starting days after LT | 20 (5-57) | 22 (6-140) | 20 (4-84) | 18 (5-232) |
|
|
Note: Data are expressed as number (%) or median (range). CSA: cyclosporine; MMF: mycophenolate mofetil; LT: liver transplantation.
|
